IL6 and cancer: Once adipocytes are activated by cancer cells, they will ultimately secrete enhanced levels of pro-inflammatory cytokines, including interleukin-6 (IL-6), which are also secreted by cancer cells and contribute to inducing the release of FAs from adipocyte triglyceride stores (36, 64) so that the progression of cancer could be facilitated.